Aardvark Therapeutics, Inc.
AARD
$8.49
-$0.50-5.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.37M | -9.31M | -8.78M | -4.18M | -5.45M |
| Total Depreciation and Amortization | 11.00K | 5.00K | -121.00K | 87.00K | -2.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 127.00K | 274.00K | 358.00K | 236.00K | 63.00K |
| Change in Net Operating Assets | 4.39M | -2.36M | 815.00K | -96.00K | 1.17M |
| Cash from Operations | -9.84M | -11.39M | -7.73M | -3.96M | -4.22M |
| Capital Expenditure | -91.00K | -- | -6.00K | -5.00K | -93.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.50M | -112.62M | -11.89M | -- | -- |
| Cash from Investing | 9.41M | -112.62M | -11.90M | -5.00K | -93.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.00K | 91.19M | 163.00K | 169.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | 85.00M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -77.00K | -2.31M | -1.18M | -105.00K | -2.06M |
| Cash from Financing | -71.00K | 88.88M | -1.01M | 64.00K | 82.94M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -506.00K | -35.14M | -20.64M | -3.90M | 78.63M |